This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02181/identifier/bindingdb/

Statements

Subject Item
n2:DB02181
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB02181 n10:DB02181
dcterms:title
2'-Deoxyguanosine-5'-Triphosphate
adms:identifier
n9:46506790 n11:DGT n12:13602803 n13:DB02181 n14:C00286 n15:21687 n16:16497
n3:synthesisReference
Carl W. Fuller, Mark McDougall, Shiv Kumar, "Derivatives of 7-deaza -2'-deoxyguanosine-5'-triphosphate, preparation and use thereof." U.S. Patent US06906185, issued June 14, 2005.
n3:IUPAC-Name
n4:271B455C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4562-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4561-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B455E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B455F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4560-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B455A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B455B-363D-11E5-9242-09173F13E4C5 n4:271B4558-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4559-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4568-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4569-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4563-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4564-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4566-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4565-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4567-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
2564-35-4
n3:Bioavailability
n4:271B456E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4570-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4571-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B456D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B456C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B456F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B455D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B456A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B456B-363D-11E5-9242-09173F13E4C5